Sino Biopharmaceutical Limited: Colorectal Neoplasms trials
The registry lists 11 Colorectal Neoplasms studies with Sino Biopharmaceutical Limited as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 7Phase 2 5Phase 3 2Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has SpreadNot yet recruitingNCT07844187Phase 1/2
- A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.RecruitingNCT07653685Phase 1/2
- To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant TumorsNot yet recruitingNCT06948539Phase 1
- A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.RecruitingNCT06010901Phase 1
- A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOxStatus unknownNCT05068206Phase 2
- A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal CancerActive, not recruitingNCT04854668Phase 3
- A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal CancerStatus unknownNCT04337879Phase 1/2
- Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer PatientsCompletedNCT03974594Phase 1
- Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)CompletedNCT02332499Phase 2/3
- Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver MetastasesStatus unknownNCT01959061Phase 4
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1